Literature DB >> 21821299

Molecular aptamers for drug delivery.

Weihong Tan1, Hui Wang, Yan Chen, Xiaobing Zhang, Haizhen Zhu, Chaoyong Yang, Ronghua Yang, Chen Liu.   

Abstract

The active targeting of drugs in a cell-, tissue- or disease-specific manner represents a potentially powerful technology with widespread applications in medicine, including the treatment of cancers. Aptamers have properties such as high affinity and specificity for targets, easy chemical synthesis and modification, and rapid tissue penetration. They have become attractive molecules in diagnostics and therapeutics rivaling and, in some cases, surpassing other molecular probes, such as antibodies. In this review, we highlight the recent progress in aptamer-mediated delivery for therapeutics and disease-targeting based on aptamer integration with a variety of nanomaterials, such as gold nanorods, DNA micelles, DNA hydrogels and carbon nanotubes.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21821299      PMCID: PMC3218254          DOI: 10.1016/j.tibtech.2011.06.009

Source DB:  PubMed          Journal:  Trends Biotechnol        ISSN: 0167-7799            Impact factor:   19.536


  67 in total

1.  Inhibition of cell adhesion by anti-P-selectin aptamer: a new potential therapeutic agent for sickle cell disease.

Authors:  Diana R Gutsaeva; James B Parkerson; Shobha D Yerigenahally; Jeffrey C Kurz; Robert G Schaub; Tohru Ikuta; C Alvin Head
Journal:  Blood       Date:  2010-10-06       Impact factor: 22.113

2.  Fluorescence-activated cell sorting for aptamer SELEX with cell mixtures.

Authors:  Günter Mayer; Marie-Sophie L Ahmed; Andreas Dolf; Elmar Endl; Percy A Knolle; Michael Famulok
Journal:  Nat Protoc       Date:  2010-12-02       Impact factor: 13.491

3.  Detecting immobilized protein kinase C isozymes with RNA aptamers.

Authors:  R Conrad; A D Ellington
Journal:  Anal Biochem       Date:  1996-11-15       Impact factor: 3.365

4.  Aptamers: the emerging class of future anticoagulation for vascular disease.

Authors:  Wiktor Kuliczkowski; James Floyd; Alex Malinin; Victor Serebruany
Journal:  Expert Rev Cardiovasc Ther       Date:  2010-04

5.  Comparative studies of in vitro and in vivo function of three different shaped bioartificial pancreases made of agarose hydrogel.

Authors:  H Yang; H Iwata; H Shimizu; T Takagi; T Tsuji; F Ito
Journal:  Biomaterials       Date:  1994-01       Impact factor: 12.479

6.  DNA-based micelles: synthesis, micellar properties and size-dependent cell permeability.

Authors:  Haipeng Liu; Zhi Zhu; Huaizhi Kang; Yanrong Wu; Kwame Sefan; Weihong Tan
Journal:  Chemistry       Date:  2010-03-22       Impact factor: 5.236

7.  Targeting pericytes with a PDGF-B aptamer in human ovarian carcinoma models.

Authors:  Chunhua Lu; Mian M K Shahzad; Myrthala Moreno-Smith; Yvonne G Lin; Nicholas B Jennings; Julie K Allen; Charles N Landen; Lingegowda S Mangala; Guillermo N Armaiz-Pena; Rosemarie Schmandt; Alpa M Nick; Rebecca L Stone; Robert B Jaffe; Robert L Coleman; Anil K Sood
Journal:  Cancer Biol Ther       Date:  2010-02-16       Impact factor: 4.742

8.  The discovery and characterization of a novel nucleotide-based thrombin inhibitor.

Authors:  L C Griffin; J J Toole; L L Leung
Journal:  Gene       Date:  1993-12-27       Impact factor: 3.688

9.  Triggered content release from optimized stealth thermosensitive liposomes using mild hyperthermia.

Authors:  Li Li; Timo L M ten Hagen; Debby Schipper; Tom M Wijnberg; Gerard C van Rhoon; Alexander M M Eggermont; Lars H Lindner; Gerben A Koning
Journal:  J Control Release       Date:  2010-01-13       Impact factor: 9.776

10.  An improved method for the in vitro evolution of aptamers and applications in protein detection and purification.

Authors:  Michael B Murphy; Shirin T Fuller; Paul M Richardson; Sharon A Doyle
Journal:  Nucleic Acids Res       Date:  2003-09-15       Impact factor: 16.971

View more
  48 in total

1.  Materiomics for Oral Disease Diagnostics and Personal Health Monitoring: Designer Biomaterials for the Next Generation Biomarkers.

Authors:  Wenjun Zhang; Ming L Wang; Sammy Khalili; Steven W Cranford
Journal:  OMICS       Date:  2016-01

Review 2.  Microfluidic approaches to rapid and efficient aptamer selection.

Authors:  Hui Lin; Weiting Zhang; Shasha Jia; Zhichao Guan; Chaoyong James Yang; Zhi Zhu
Journal:  Biomicrofluidics       Date:  2014-07-16       Impact factor: 2.800

3.  Nucleic acid aptamers as stabilizers of proteins: the stability of tetanus toxoid.

Authors:  Nishant Kumar Jain; Hardik C Jetani; Ipsita Roy
Journal:  Pharm Res       Date:  2013-04-09       Impact factor: 4.200

Review 4.  Nanoscale delivery systems for microRNAs in cancer therapy.

Authors:  Sanda Boca; Diana Gulei; Alina-Andreea Zimta; Anca Onaciu; Lorand Magdo; Adrian Bogdan Tigu; Calin Ionescu; Alexandru Irimie; Rares Buiga; Ioana Berindan-Neagoe
Journal:  Cell Mol Life Sci       Date:  2019-10-21       Impact factor: 9.261

5.  Assembly of aptamer switch probes and photosensitizer on gold nanorods for targeted photothermal and photodynamic cancer therapy.

Authors:  Jian Wang; Guizhi Zhu; Mingxu You; Erqun Song; Mohammed Ibrahim Shukoor; Kejing Zhang; Meghan B Altman; Yan Chen; Zhi Zhu; Cheng Zhi Huang; Weihong Tan
Journal:  ACS Nano       Date:  2012-06-04       Impact factor: 15.881

Review 6.  Aptamer-Functionalized Nanoparticles as "Smart Bombs": The Unrealized Potential for Personalized Medicine and Targeted Cancer Treatment.

Authors:  Gregory Benedetto; C Greer Vestal; Christine Richardson
Journal:  Target Oncol       Date:  2015-12       Impact factor: 4.493

Review 7.  Therapeutic potential of aptamer-siRNA conjugates for treatment of HIV-1.

Authors:  Jiehua Zhou; John J Rossi
Journal:  BioDrugs       Date:  2012-12-01       Impact factor: 5.807

8.  Inhibition of hepatitis C virus infection by DNA aptamer against envelope protein.

Authors:  Darong Yang; Xianghe Meng; Qinqin Yu; Li Xu; Ying Long; Bin Liu; Xiaohong Fang; Haizhen Zhu
Journal:  Antimicrob Agents Chemother       Date:  2013-07-22       Impact factor: 5.191

Review 9.  Tetraspanins as regulators of the tumour microenvironment: implications for metastasis and therapeutic strategies.

Authors:  S Detchokul; E D Williams; M W Parker; A G Frauman
Journal:  Br J Pharmacol       Date:  2014-12       Impact factor: 8.739

10.  Self-assembled, aptamer-tethered DNA nanotrains for targeted transport of molecular drugs in cancer theranostics.

Authors:  Guizhi Zhu; Jing Zheng; Erqun Song; Michael Donovan; Kejing Zhang; Chen Liu; Weihong Tan
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-29       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.